Dry Fasting — The Record

Pathway atlas · node 41 of 41

Immune-checkpoint signaling (T-cell co-inhibition)

What fasting does to this node, by modality, by system and by grade. Disconfirming evidence is reported first.

Founder's role line (READ): "Co-inhibitory receptor pathways that restrain T-cell activation to maintain self-tolerance and prevent excessive immune responses." Key components (READ): PDCD1 (PD-1), CD274 (PD-L1), CTLA4, LAG3, TIGIT

STATED FIRST, BEFORE ANY EVIDENCE. This node is about self-tolerance and the restraint of T-cell activation, which is what the founder's own role line says. Nothing in this node is a cancer treatment claim, a statement that fasting treats any disease, or advice to anyone to fast. The one human trial that measured checkpoint receptors under a fasting-type diet reported no tumor response, progression or survival endpoint of any kind, and said so itself. The one animal study that combined restriction with a checkpoint drug reported the drug losing its effect. Those two facts are the top of this node, not a footnote at the bottom.

The two things kept rigorously separate in this node:

DRY status

DRY: none located. Queries run:

Two human dawn-to-dusk dry-fasting studies were located and opened:

So: the dry-fasting human channel is productive as a literature and empty for this node, and by the brief's own definitions dawn-to-dusk with no food and no water is RAMADAN, not absolute DRY. Absolute DRY and checkpoint signaling: nothing located.

Disconfirming and null first

1. Ramadan fasting did NOT change T-cell or B-cell subpopulations in humans, over two years of follow-up. Siadat Z, Rastin M, Tabasi N, Rezaee A, Mahmoudi M. "Evaluation of the Effects of Ramadan Fasting on Lymphocyte Subpopulations in a Two-year Follow-up." J Fasting Health. 2014;2(1):31-36. 38 healthy Muslims (9 female, 29 male), aged 17 to 51, Ramadan in 1999 and 2000 (winter), roughly 12 to 12.5 h/day, at least 22 of 30 days observed, bloods two days before and one day before the end. MEASURED, all non-significant:

2. Prolonged water-only fasting INCREASED systemic inflammation in humans. Commissati S, Lastra Cagigas M, Masedunskas A, Petrucci G, Tosti V, De Ciutiis I, Rajakumar G, Kirmess KM, Meyer MR, Goldhamer A, Kennedy BK, Hatem D, Rocca B, Fiorito G, Fontana L. "Prolonged fasting promotes systemic inflammation and platelet activation in humans: A medically supervised, water-only fasting and refeeding study." Mol Metab. 2025 Apr 21;96:102152. doi:10.1016/j.molmet.2025.102152. PMID 40268190. PMCID PMC12088818. 20 middle-aged volunteers (11 women, 9 men; mean age 52.2; mean BMI 28.8), single-arm, no control, medically supervised water-only fast averaging 9.8 +/- 3.1 days, then about 5.3 days of guided plant-based refeeding. Protocol deviations MEASURED: six participants switched to broth or juice on medical advice, and a few drank small amounts during the fast. MEASURED: hsCRP rose about 129 percent during fasting, Wilcoxon P = 0.0004, returning to baseline after refeeding in all but one participant. Hepcidin, ferritin, midkine, MMP-9, IL-8 and PAFAH (PLA2G7) all increased significantly on SOMAScan. Urinary 11-dehydro-TXB2 rose 21 percent during fasting and 36 percent after refeeding. vWF and soluble GP1Balpha mildly increased. Platelet counts did not change. Prothrombin did not change. MEASURED unit inconsistency in the source, reported: Table 1 gives CRP 1.7 to 3.9 mg/dL while the abstract gives 2.8 to 4.3 mg/L for the validation cohort. MEASURED: in a retrospective validation cohort of 1,422 people on modified fasting (Wilhelmi de Toledo et al., 2019), 66.6 percent had a significant CRP rise. The authors describe that cohort as retrospective. MEASURED: this study did not report lymphocyte counts or immune-cell subsets. Its immune findings are plasma proteins and inflammatory markers. This cuts directly against any reading of fasting as immune-quieting. The direction is the opposite of what a reader expects, it is human, and the n is 20 with no control arm. 3. In mice, caloric restriction made a PD-1 drug stop working. Dung NT, Susukida T, Ucche S, He K, Sasaki S, Hayashi R, Hayakawa Y. "Calorie Restriction Impairs Anti-Tumor Immune Responses in an Immunogenic Preclinical Cancer Model." Nutrients. 2023;15(16):3638. doi:10.3390/nu15163638. 40 percent CR from the day of tumor inoculation, C57BL/6J mice, subcutaneous B16-OVA melanoma, endpoints through day 16. MEASURED: CR significantly slowed tumor growth on its own. MEASURED: CR did not change CD4+ or CD8+ tumor infiltration, the CD8/CD4 ratio, or CD44-high effector CD8+ cells. MEASURED: CD8 depletion increased tumor growth in control-diet mice but made no difference in CR mice, which the authors read as CR blunting CD8-dependent control; the authors' own results section notes those depletion comparisons were not statistically significant. MEASURED: CD8+ cells from tumor-draining nodes of CR mice had lower oxygen consumption and lower extracellular acidification; anti-PD-1 shifted those cells toward glycolysis in control mice but not in CR mice. READ, authors' own words: "Anti-PD-1 Ab treatment lost its efficacy to suppress tumor growth." MEASURED: anti-PD-1 still increased tumor-infiltrating CD8+ T cells in CR mice. MEASURED limits: authors call it exploratory, n = 3 to 21 per group with large variation, mouse only; PD-L1 and CTLA-4 were not examined. The extraction notes the abstract's patient-level conclusions are extrapolations. This is the single most important row for keeping this node gotcha-proof. The restriction-plus-checkpoint literature contains a published failure, in the same direction of intervention, and it is listed before any positive. 4. The human positive has no efficacy endpoint, no randomization and no control arm. See 41.1 below. READ, authors' own words: "Phase II/III clinical trials are needed to investigate FMD antitumor activity/efficacy." MEASURED: the primary endpoint was safety. No tumor response, progression or survival endpoint was reported. 5. Checkpoint-pathway direction under restriction is contested in animals. Located and NOT opened, recorded as retrieval debts and named so both sides are visible: a Molecular Cell 2021 report that energy status dictates PD-L1 protein abundance; a Nature Communications 2023 report on FMD in mice and immunotherapy side effects; a Nutrients-indexed and a Nature-indexed report that dietary restriction reprograms CD8+ T cell fate to enhance immunotherapy response; a biorxiv 2026 report that calorie restriction upregulates islet PD-L1 in NOD mice; and the Dung 2023 impairment above. The animal literature points in both directions. No winner is picked here.

Graded rows

#ClaimModalitySpecies / systemTierGradeSourceTag
41.1A 5-day FMD repeated every 21 to 28 days (median 4 cycles, up to 8) changed checkpoint-receptor expression on human blood cells: PD-L1+ monocytes down, activated PD-1+CD69+ CD8+ T cells up, PD-1+LAG3+TIM3+ exhausted and hyperexhausted cells down, PD-1+ CD8+ cells lacking LAG3 and TIM3 upFMDhuman, single-arm, 101 enrolled, 38 immune-profiled, plus 22 in a window-of-opportunity trialH3CVernieri C, Fucà G, Ligorio F, et al. Cancer Discov. 2022;12(1):90-107. doi:10.1158/2159-8290.CD-21-0030. PMID 34789537. PMCID PMC9762338MEASURED, direction; no effect sizes given in the text opened
41.2In the same trial, total CD14+ monocytes, HLA-DR-negative monocytic MDSCs, CD15+ granulocytes, CD3+CD25+ cells and Tregs all fell, and CD3-CD16+CD56dim NK cells, granzyme B and IFN-gamma in CD8+ T cells roseFMDsameH3CVernieri 2022MEASURED, direction
41.3In the window-of-opportunity sub-analysis, intratumoral CTLA4 and LGALS9 transcripts rose, and they were the only checkpoint-related genes that didFMDhuman tumor tissue, 22 patients, mostly biopsy versus surgical specimen, unplanned interim analysis, no control armH3CVernieri 2022MEASURED
41.4That trial reported no efficacy endpoint. Primary endpoint was safety: grade 3/4 FMD-related adverse events in 12.9 percent (90 percent CI 7.8 to 19.7), below the prespecified 20 percent thresholdFMDhumanH3CVernieri 2022MEASURED
41.5TIGIT and absolute lymphocyte counts were not reported in the text opened, so two of the founder's five components are unmeasured even in the one human checkpoint studyFMDhumann/an/aVernieri 2022MEASURED as an absence of reporting
41.6Ramadan fasting produced no significant change in CD3+, CD4+, CD8+, CD19+, HLA-DR+CD3+ or the CD4/CD8 ratio in 38 healthy adults across two RamadansRAMADANhuman, pre/post, two-year follow-upH3CSiadat 2014, J Fasting Health 2(1):31-36MEASURED, null
41.7A 9.8-day water-only fast raised hsCRP about 129 percent (P=0.0004) and raised hepcidin, ferritin, midkine, MMP-9, IL-8 and PAFAH; platelet counts unchangedPFhuman single-arm, n=20, no controlH3CCommissati 2025, Mol Metab 96:102152MEASURED
41.8In a retrospective cohort of 1,422 people on modified fasting, 66.6 percent had a significant CRP risePF / FMD-adjacent, "modified fasting"human, retrospectiveH2 observationalCWilhelmi de Toledo et al. 2019, READ through Commissati 2025, NOT openedREAD, secondhand; retrieval debt
41.940 percent CR abolished the tumor-growth effect of anti-PD-1 in mice while not changing CD4+ or CD8+ tumor infiltrationCRmouse, B16-OVA melanomaA1CDung 2023, Nutrients 15(16):3638MEASURED
41.10Energy status dictates PD-L1 protein abundanceC1 or A1, not determinednot openedC1CMolecular Cell 2021, located, NOT openedlocated only; retrieval debt
41.11Calorie restriction upregulates islet PD-L1 and lowers autoimmune diabetes onset in NOD miceCRmouseA1Cbiorxiv 2026.02.15.705935, located, NOT opened, preprintlocated only; retrieval debt
41.12Fasting lowers insulin and IGF-1 and raises ketones, and those change T-cell metabolism, therefore checkpoint signaling changes. Hops: fasting to those fuels (other slices), fuels to T-cell metabolism (measured in mice by Dung 2023), T-cell metabolism to checkpoint signaling (not measured in any human source located). Inference, not a human fasting effectn/ahops shownMCderivation statedinference, shown and labeled

Conflict left unresolved, named on both sides

Open questions


# CROSS-NODE NOTES FOR THIS SLICE

What the founder's component lists reveal

Of the 28 named key components across these 8 nodes, the number with any human fasting-intervention measurement located in this sweep is two: VEGFA (node 40, under CR only) and PDCD1/PD-1 plus CD274/PD-L1 plus CTLA4 plus LAG3 (node 41, under FMD only, single-arm). Counting generously that is 5 of 28. MEASURED as an absence of measurement. Absence is not evidence of no effect.

Modality distribution across all rows in this file

CR is the most-represented modality and CR is not fasting. Every human row in nodes 37 and 40 is CR. The only human rows under a true fasting modality in the whole slice are: PF in node 37 (Luo 2026, preprint, null at day 10), PF in node 41 (Commissati 2025, inflammation up), FMD in node 41 (Vernieri 2022, single-arm), and RAMADAN in node 41 (Siadat 2014, null). That is four human studies under true fasting modalities across eight nodes, three of which are null or point against the expected direction. Those four studies supply nine graded rows; the per-row count is in the receipt block.

Why the DRY column is empty and why that is the protective finding

Human dry-fasting research exists and was opened (two Mindikoglu studies, 14 and 8 subjects, both uncorrected for multiple testing, one with no control group and one a 3-versus-3 pilot). It is dawn-to-dusk, which the brief defines as RAMADAN. It measured none of the 28 components across these eight nodes. Writing any of these eight nodes as a dry-fasting mechanism would require an identifier that does not exist in the retrieved literature. The empty column is the correct column.


# RECEIPT BLOCK

Nodes

Rows by tier

Counts computed off the graded-row tables in this file by enumerating every row id, not estimated. Total distinct graded rows: 53.

TierRowsRow ids
H1737.1, 37.2, 37.3, 37.4, 40.1, 40.2, 40.3
H2340.5 (observational), 41.8 (observational), 39.5 (human crossover, but the intervention was carbohydrate, so it is not this node under fasting)
H31037.5, 37.6, 37.7, 40.4, 41.1, 41.2, 41.3, 41.4, 41.6, 41.7
A12234.1, 34.2, 35.1, 35.2, 35.3, 35.4, 35.5, 36.1, 36.2, 36.3, 37.8, 37.9, 38.1, 38.2, 38.3, 38.4, 39.1, 39.2, 39.3, 40.7, 41.9, 41.11
A20none located in this slice
C1240.6, 41.10
M734.3, 35.6, 36.4, 38.5, 39.4, 40.8, 41.12
absence-of-measurement rows, no tier applicable237.10, 41.5

Human rows (H1 + H2 + H3) = 20 of 53, and 19 of those 20 sit in only three nodes: 37, 40 and 41. Human rows under a true fasting modality (PF, FMD, RAMADAN, TRE or IF; excluding CR, KD, observational rows and the one non-fasting row) = 9: 37.5, 37.6, 37.7 (PF), 41.1, 41.2, 41.3, 41.4 (FMD), 41.6 (RAMADAN), 41.7 (PF). Of those nine, four are explicit nulls or point against the expected direction (37.5, 37.6, 41.6, 41.7), and the remaining five are all from one single-arm unrandomized trial with no efficacy endpoint. Stated exactly: of the 20 human rows, 7 are CR (37.1 to 37.4, 40.1 to 40.3), 1 is CR single-arm (40.4), 3 are PF (37.5 to 37.7), 1 is PF (41.7), 4 are FMD (41.1 to 41.4), 1 is RAMADAN (41.6), 2 are observational non-intervention (40.5, 41.8), and 1 is not a fasting intervention at all (39.5).

Grades by node

No node in this slice reaches grade A. No node has multiple independent human trials converging.

Language channels

LanguageQuery runResult
Englishmany, including CALERIE caloric restriction trial epigenetic clock DunedinPACE null Horvath PhenoAge GrimAge results, "dry fasting" DNA methylation epigenetic OR immune OR VEGF OR Myc OR EZH2 human study, fasting EZH2 H3K27me3 nutrient deprivation starvation Polycomb PRC2 mouse liver, fasting SWI/SNF BRG1 SMARCA4 ARID1A chromatin remodeling nutrient starvation liver, fasting epithelial mesenchymal transition EMT Snail ZEB1 E-cadherin nutrient starvation mouse in vivo, "caloric restriction" OR fasting integrin FAK phosphorylation reduced adipose tissue extracellular matrix in vivo, fasting VEGF human serum plasma time-restricted eating randomized trial angiogenesis biomarker, Ramadan intermittent fasting serum VEGF human levels study, fasting PD-1 CTLA-4 immune checkpoint expression T cells mouse study caloric restriction, Ramadan fasting lymphocyte count CD4 CD8 natural killer cells human immune changes, prolonged fasting human T cell PD-1 expression lymphocyte subsets flow cytometry fasting mimicking diet humans, fasting MYC expression liver mouse starvation c-Myc downregulation nutrient deprivation, intermittent fasting epigenetic age DNA methylation human randomized trial Horvath clock, time-restricted eating DNA methylation human trial epigenome-wide results methylome, Ramadan fasting DNA methylation epigenetic age human studyPRODUCTIVE. Every source in this file came through this channel.
Russianсухое голодание метилирование ДНК иммунитет лимфоциты исследование ФилоновRUN, EMPTY for these eight nodes. Returned Filonov's dry-fasting books (books.google.com, vesbook.ru, filonov.net, e-reading.club, ruslit.net) and unrelated indexed papers. No primary study measuring any of the 28 components was located. The Filonov tradition is present as books and practitioner essays, not as indexed primary measurement, and nothing in it was opened or cited here.
Turkishnot run as a Turkish-language query. A Turkish journal source was reached through the English channel: Işık T, IGUSABDER 2025;26:722-737, a Turkish-language review with a Turkish title, opened and cited at node 37.PARTIAL. One Turkish-journal source opened; no Turkish-language query was issued.
Chinesenot runBLOCKED. See channel block below. Intended query: 禁食 DNA甲基化 表观遗传时钟 人体 研究 plus 禁食 EZH2 H3K27me3 小鼠 肝脏
Japaneseissued and refused mid-run: 短期断食 DNAメチル化 ヒト 研究 エピジェネティック 時間制限摂食BLOCKED. The query was submitted and the search tool returned a budget refusal, not a result set. Not an empty channel.
Germannot runBLOCKED. Intended query: Heilfasten DNA-Methylierung epigenetische Uhr Mensch Studie Buchinger
Frenchnot runBLOCKED. Intended query: jeûne prolongé méthylation ADN horloge épigénétique humain étude
Arabicnot runBLOCKED. Intended query: الصيام مثيلة الحمض النووي الخلايا اللمفاوية دراسة بشرية
Persiannot runBLOCKED. Intended query: روزه داری متیلاسیون DNA لنفوسیت مطالعه انسانی
Spanishnot runBLOCKED. Intended query: ayuno prolongado metilación del ADN reloj epigenético humanos ensayo
Koreannot runBLOCKED. Intended query: 단식 DNA 메틸화 후성유전 시계 인간 연구

Languages done / total: 2 of 11 run (English productive, Russian empty); 1 of 11 partially served through a foreign-language journal reached in English (Turkish); 8 of 11 blocked by the shared WebSearch budget, not by absence of literature. This is a channel block and a debt, not a null. A worldwide all-language sweep for these eight nodes has not been completed and this file does not claim one.

Channels blocked, with reason, never retried after the block

ChannelReasonAction taken
api.crossref.orgAgent proxy refused, connect_rejected, HTTP 403. Host not allowed for this session.Abandoned. Citations sourced from publisher pages instead.
www.nature.comclient_error on fetch, nothing retrieved.Routed to PMC and link.springer.com.
pubmed.ncbi.nlm.nih.govReturned a shell page with no record content.Routed to publisher hosts.
pmc.ncbi.nlm.nih.govGoogle reCAPTCHA "Checking your browser" interstitial on repeated articles (PMC10458233, PMC5033683, PMC9799188, PMC5712070, PMC8091980). Productive earlier in the run (PMC10148951, PMC12088818, PMC7010817, PMC5741368, PMC9731888, PMC12186377, PMC9762338, PMC7602406, PMC5033683/table/T4) then captcha-walled.Stopped using after the captcha pattern established. Routed to academic.oup.com, mdpi.com, journals.plos.org, link.springer.com, biorxiv, medrxiv, dergipark.org.tr, intechopen.com, sochob.cl, applications.emro.who.int, eurekalert.org.
aacrjournals.org (and the article-pdf path)client_error on fetch, nothing retrieved.Volume, issue and first page read from the publisher's article URL path only. Authors taken from the AACR press release via eurekalert.org. Full citation remains a debt.
www.cell.comclient_error on fetch, nothing retrieved.Routed to a publisher-identical PDF on sochob.cl for the Harney 2021 paper. The iScience 2025 paper could not be routed.
onlinelibrary.wiley.comclient_error on fetch, nothing retrieved.Zhao et al. Aging Cell left as a debt.
journals.plos.orgOne RATE_LIMIT_EXCEEDED from the target, cleared on a single re-fetch as the error text instructed.Fetched successfully on the second, single attempt.
WebSearch toolTurn budget exhausted at 200 calls, shared across every agent in the turn.Switched to WebFetch-only for the remainder of the run. No workaround attempted through curl, a browser, a reader, a proxy or an archive service.

Retrieval debts: located and NOT opened

1. Cancer Research 2016;76(14):4226, "Dietary Weight Loss and Exercise Effects on Serum Biomarkers of Angiogenesis in Overweight Postmenopausal Women: A Randomized Controlled Trial", PMCID PMC5033683. Table T4 was opened; the article body was not. Full author list, DOI and PMID not retrieved. Authors Duggan and senior author McTiernan taken from the AACR press release, not from the paper. This is the H1 source for node 40. 2. Waziry et al., medRxiv 2021.09.21.21263912, Table 3. Holds the confidence intervals for the Horvath, Hannum, PhenoAge, GrimAge and DunedinPACE estimates. Not retrievable from the full-text page. This is why the preprint-versus-published DunedinPACE sign conflict at node 37 item 7 is unresolved. 3. Waziry 2023 Supplementary Information, Supplementary Figure 3a and 3b, Supplementary Data 1 and 2. Hold the per-clock Horvath and Hannum results for the published version. Not opened. 4. Zhao et al., Aging Cell, doi:10.1111/acel.12947, SLC1A5 glutamine transporter as a MYC target in long-lived Myc hypomorphic mice. Wiley refused. Node 34 row 34.3 rests on title and indexing only. 5. Hamad Bin Khalifa University thesis, epigenome-wide DNA methylation analysis of Ramadan fasting effects on pediatric MASLD. Located at elmi.hbku.edu.qa. Not opened. Relevant to node 37 and to the RAMADAN modality. 6. Nutrients 2024;16(19):3260, EZH2-mediated H3K27 trimethylation in mouse liver as an early event induced by high-fat diet. Located at mdpi.com. Not opened. Relevant to node 35 as a feeding comparator. 7. Dalmas et al. 2011, surgery-induced weight loss and VEGF in humans. Located through Korybalska 2017. Not opened. Node 40 row 3 of the disconfirming section. 8. Halberg et al. 2009, adipocyte HIF-1alpha overexpression with no VEGF induction. Located through Korybalska 2017. Not opened. Node 40 row 4 of the disconfirming section. 9. Lolmede et al. 2003, hypoxia and VEGF in 3T3-F442A adipocytes. Located through Korybalska 2017. Not opened. Node 40 row 40.6. 10. Csiszar et al., 10 years of CR in rhesus macaques and VEGF. Located through Korybalska 2017. Not opened, and the direction is ambiguous in the secondary source. Node 40 row 40.7. 11. Miyazawa-Hoshimoto et al., serum VEGF and anthropometry in obese humans. Located through Korybalska 2017. Not opened. Node 40 row 40.5. 12. Silha et al. 2005, angiogenic factors in overweight and obese humans, VEGF direction not specified in the secondary source. Located through Korybalska 2017. Not opened. 13. Wilhelmi de Toledo et al. 2019, 1,422-person modified-fasting cohort with the 66.6 percent CRP rise. Located through Commissati 2025. Not opened. Node 41 row 41.8. 14. Molecular Cell 2021, "Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade." cell.com refused. Node 41 row 41.10. 15. Nature Communications 2023, FMD in mice, cancer growth and immunotherapy-associated side effects. nature.com refused. Node 41 item 5. 16. "Dietary restriction reprograms CD8+ T cell fate to enhance anti-tumour immunity and immunotherapy responses." Located at PMC12727518 and experts.umn.edu. PMC captcha-walled. This is a named side of the unresolved animal conflict at node 41 and it is unopened. 17. biorxiv 2026.02.15.705935, calorie restriction upregulates islet PD-L1 in NOD mice. Preprint. Located, not opened. Node 41 row 41.11. 18. "Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells." Located at sciencedirect.com. Not opened. Node 41. 19. PMC5712070, "Ramadan Fasting Exerts Immunomodulatory Effects: Insights from a Systematic Review." PMC captcha-walled. This is the systematic review for the RAMADAN immune channel and it is unopened. Node 41's RAMADAN evidence therefore rests on one primary study (Siadat 2014) and not on the review. 20. iScience 2025, S2589-0042(25)01133-2, "Altered immunometabolic response to fasting in humans living with obesity." cell.com refused. Human fasting immunometabolism. Node 41. 21. Nutrients 18(15):2514, doi:10.3390/nu18152514, "Exploring the Immunomodulatory Effects of Fasting-Mimicking Diet in Healthy Individuals: A Pilot Study." Located, not opened. Node 41. 22. Işık 2025's primary sources for rows 37.8 and 37.9 (the mouse offspring DNMT study and the 16:8 vascular-dementia methylation study). Read secondhand through the review only. Not opened. 23. PMC6953068 and PMC8091980, hepatic and multi-tissue fasting and refeeding transcriptional response in mice, for a MYC check at node 34. PMC captcha-walled. 24. Vernieri 2022 beyond character 100,000, including TIGIT and absolute lymphocyte counts. Not read. Node 41 row 41.5. 25. Korenfeld 2025 beyond character 100,000, including the Discussion, where a remodeler could still be named. Not read. Node 36. 26. Byun 2020 beyond character 100,000, where EED and SUZ12 could still be mentioned. Not read. Node 35.

Compliance statement

← 40. Angiogenesis (VEGF axis) All 41 nodes


dryfasting.com has been published since 2014. This evidence record was compiled on 22 November 2026. Every row names the fasting modality the study actually ran, the system it was measured in and the grade. Where no source carries a DOI or PMID the row says so rather than supplying one. Nothing is sold on this site.